108319-50-2

Upstream product

• 98-88-4 benzoyl chloride 
• 14133-63-2 methyl 2,3-O-isopropylidene-α-L-rhamnoside 
• 14133-63-2 methyl 2,3-O-isopropylidene-α-D-rhamnopyranoside 
• 15830-63-4 methyl 6-deoxy-2,3-O-isopropylidene-α-D-lyxo-hexopyranosid-4-ulose 
• 104846-19-7 methyl 6-deoxy-2,3-O-isopropylidene-α-D-talopyranoside 
• 77-76-9 2,2-dimethoxy-propane 

Downstream Products

• 108319-51-3 4-O-benzoyl-2-bromo-2,6-dideoxy-3-O-formyl-α-D-galactopyranosyl bromide 
• 108319-55-7 benzyl 4-O-benzoyl-3-O-(4-O-benzoyl-2-bromo-2,6-dideoxy-3-O-formyl-β-D-glucopyranosyl)-2-bromo-2,6-dideoxy-β-D-galactopyranoside 
• 108319-54-6 benzyl 4-O-benzoyl-3-O-(4-O-benzoyl-2-bromo-2,6-dideoxy-3-O-formyl-α-D-glucopyranosyl)-2-bromo-2,6-dideoxy-β-D-galactopyranoside 
• 108319-53-5 benzyl 4-O-benzoyl-2-bromo-2,6-dideoxy-β-D-galactopyranoside 
• 108319-52-4 benzyl 4-O-benzoyl-2-bromo-2,6-dideoxy-3-O-formyl-β-D-galactopyranoside 
• 108319-56-8 benzyl 4-O-benzoyl-3-O-(2,6-dideoxy-3-O-formyl-β-D-arabino-hexopyranosyl)-2,6-dideoxy-β-D-lyxo-hexopyranoside 
• 51288-33-6 methyl 3,4-di-O-benzoyl α-L-rhamnopyranoside 
• 135129-62-3 methyl 3,4-di-O-benzoyl-2-O-(2,3,4-tri-O-benzoyl-α-L-rhamnopyranosyl)-α-L-rhamnopyranoside 
• 101068-99-9 methyl 2,3,4-tri-O-benzoyl α-L-rhamnopyranoside 
• 101068-96-6 Benzoic acid (2S,3S,4R,5R,6R)-4,5-diacetoxy-6-methoxy-2-methyl-tetrahydro-pyran-3-yl ester 
• 101068-97-7 Benzoic acid (2S,3S,4S,5R,6R)-4-acetoxy-5-hydroxy-6-methoxy-2-methyl-tetrahydro-pyran-3-yl ester 
• 101068-98-8 methyl 2-O-acetyl-4-O-benzoyl-α-L-rhamnopyranoside 
• 89202-42-6 methyl 3-O-acetyl-2,4-di-O-benzoyl-α-L-rhamnopyranoside 
• 149827-71-4 1-O-acetyl-2,4-di-O-benzoyl-3-O-bromoacetyl-α-L-rhamnopyranose 

Relevant academic research and scientific papers

Formation of aureolic acid oligodeoxy mono-, di-, and trisaccharides employing the dibromomethyl methyl ether reaction

2,3-Isopropylidene D-rhamnopyranoside 2 obtained from mannose was treated with dibromomethyl methyl ether to give 2,6-dideoxy-2-bromo-glucopyranosyl bromide 5. Correspondingly, the D-talo precursor 3 led to the epimeric galacto-pyranosyl bromide 4. Both g

GLYCOSAMINOGLYCAN (GAG) MIMETICS

The invention relates to compounds that are designed to mimic the structure of GAGs; methods for the preparation of the compounds; compositions comprising the compounds; and use of the compounds and compositions thereof for the anti-angiogenic, anti-metas

Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds

Disclosed are 14-aminosteroid compounds, including pharmaceutically acceptable acid salts and esters thereof, useful in treating individuals afflicted with congestive heart failure, which compounds have the general formula: STR1 wherein R3 is a

Convergent synthesis of an octasaccharide fragment of the O-specific polysaccharide of Shigella dysenteriae type 1

A stereocontrolled, convergent synthesis is described of the linear octasaccharide methyl glycoside α-L-Rhap-(1 -> 2)-α-D-Galp-(1 -> 3)-α-GlcpNAc-(1 -> 3)-α-L-Rhap-(1 -> 3)-α-L-Rhap-(1 -> 2)-α-D-Galp-(1 -> 3)-α-D-GlcpNAc-(1 -> 3)-α-L-Rhap-OMe (11), which

SYNTHESIS OF THE O-SPECIFIC POLYSACCHARIDE OF SHIGELLA FLEXNERI

A regular heteropolysaccharide built of tetrasaccharide repeating units is synthesised by means of regio- and stereospecific polycondensation of tritylated cyanoethylidene derivative.The polysaccharide obtained is identical with the O-antigenic polysaccharides of Shigella flexneri serotypes 3b, 3c, and variant Y.It also represents the basic chain of O-antigenic polysaccharides of all serotypes of this bacterium.